List of Participants - IARC Monographs on the Evaluation of

List of Participants - IARC Monographs on the Evaluation of

IARC WORKING GROUP ON THE EVALUATION OF
CARCINOGENIC RISKS TO HUMANS:
HEPATITIS VIRUSES
Lyon, 8-15 June 1993
LIST OF PARTICIPANTS
Members 1
V Beral, Cancer Epidemiology Unit, Gibson Building, The Radcliffe Infirmary, Oxford
OX2 6HE, United Kingdom
H. Blum, Department ofInternal Medicine, Medical Clinic B, Ramistrasse 100, 8091 Zurich,
Switzeriand (Vìce-Chairman)
M.-A. Buendia, Retroviruses Building, Pasteur Institute, 28 rue du Docteur Roux, 75724
Paris Cédex 15, France
J.R. Craig, St Jude Medical Center, 101 E. Valencia Mesa Drive, Fullerton, CA 92634, USA
TA. Dragani, Division of Experimental Oncology A, National Institute for the Study and
Treatment of Tumours, via Venezian 1, 20133 Milano, Italy
YT Gao, Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China
J.W. Grisham, The University of North Carolina at Chapel Hil, The School of Medicine,
Department of Pathology, CB 7525, Brinkhous-Bullitt Building, Chapel Hil, NC
27599-7525, USA
/'
A.J. Hall, Communicable Diseases Epidemiology Unit, London School of Hygiene and
Tropical Medicine, Keppel Street, London WC1E 7H'l United Kingdom
J. Kaldor, National Centre in HIV Epidemiology and Clinical Research, St Vincent's
Medical Centre, 2nd floor, 376 Victoria Street, Sydney, NSW 2010, Australia
M.C. Kew, Department of Medicine, University of Witwatersrand Medical School, 7 York
Road, Parktown, 2193 Johannesburg, South Africa
IUnable to attend: C. Bréchot, INSERM U 75, Necker-Enfants Malades, 156 rue de Vaugirard, 75742 Paris
Cédex 15, France; M. Colombo, Institute of InternaI Medicine, via Pace 9, 20122 Milan, Italy; J.L. Geri,
Department of Microbiology, Georgetown University School of Medicine-School of Dentistry, 56 Fishers
Lane, Rockvile, MD 20852, USA
-11-
12
IARC MONOGRAPHS VOLUME 59
G.M. Kirby, Lady Davis Research Institute, Jewish General Hospital, 3755 Cote St
Catherine Road, Montréal, Québec, Canada H3T 1E2
W.T London, Fox Chase Cancer Center, Liver Cancer Prevention Center, 7701 Burholme
Avenue, Philadelphia, PA 19111, USA
P.L. Marion, Department of Medicine, Division of Infectious Diseases, Stanford University
School of Medicine, Stanford, CA 94305, USA
A.B. MiIIer, Department of Preventive Medicine and Biostatistics, Faculty of Medicine,
McMurrich Building, University of Toronto, Toronto, Ontario, Canada M5S 1A8
( Chairman)
J. Monjardino, Department of Medicine, St Mary's Hospital Medical School, London
W2 1PG, United Kingdom
N. Müller, Department of Epidemiology, Harvard School of Public Health, 677 Huntington
Avenue, Boston, MA 02115, USA
K. Nishioka, Japanese Red Cross Central Blood Center, 1-31 Hiroo 4-Chome, Shibuya-ku,
Tokyo 150, Japan
M. Ozturk, Léon Bérard Centre, 28 rue Laënnec, 69373 Lyon Cédex 08, France
D. Trichopoulos, Department of Epidemiology, Harvard School of Public Health, 677
Huntington Avenue, Boston, MA 02115, USA
lARe Secretariat
B. Armstrong, Deputy Director1
P. Boffetta, Unit of Analytical Epidemiology
EX. Bosch, Unit of Field and Intervention Studies2
E. Cardis, Unit of Analytical Epidemiology
M.-J. Ghess, Unit of Carcinogen Identification and Evaluation
E. Heseltine, 24290 St Léon-sur- Vézère, France
M.A. Kane, Microbiology and Immunology Support Servces, World Health Organization,
1211 Geneva 27, Switzerland
V Krutovskikh, Unit of Multistage Carcinogenesis
D. McGregor, Unit of Carcinogen Identification and Evaluation
D. Mietton, Unit of Carcinogen Identification and Evaluation
H. Møller, Unit of Carcinogen Identification and Evaluation
R. Montesano, Unit of Mechanisms of Carcinogenesis
N. Muñoz, Unit of Field and Intervention Studies
C. Partensky, Unit of Carcinogen Identification and Evaluation
1. Peterschmitt, Unit of Carcinogen Identification and Evaluation, Geneva, Switzerland
L.r Tomatis, Director
H. Vainio, Unit of Carcinogen Identification and Evaluation
lPresent adress: Australian InstItute of Health and Welfare, GPO Box 570, Canberra ACl 261, Australia
2Present address: Institut d'Oncologia, Unitat d'Epidemiologia, Hospital Duran i Reynals, Autovi
CastelldefeIs K. 2,7, E-Q8907 Hospitalet deI Llobregat (Barcelona), Spain
PARTICIPANTS
J. Wilbourn, Unit of Carcinogen Identification and Evaluation
C. Wild, Unit of Mechanisms of Carcinogenesis
Secretarial assistance
M. Lézère
J. MitcheII
S. Reynaud
13